New hope for rare, severe psoriasis: phase 3 trial underway
NCT ID NCT06295692
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 29 times
Summary
This study tests an experimental drug, JNJ-77242113, in 19 people with two rare and severe forms of psoriasis: generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). The goal is to see if the drug can improve skin symptoms by week 16. Participants must have a diagnosis of GPP or EP and be candidates for phototherapy or systemic treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED PUSTULAR PSORIASIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dokkyo Medical University Hospital
Shimotsuga Gun, 321 0293, Japan
-
Fujita Health University Hospital
Toyoake, 470-1192, Japan
-
Hospital of the University of Occupational and Environmental Health
Kitakyushu-shi, 807-8556, Japan
-
Ichinomiya Municipal Hospital
Ichinomiya, 491-8558, Japan
-
JR Sapporo Hospital
Hokkaido, 060-0033, Japan
-
Kumamoto University Hospital
Kumamoto, 860-8556, Japan
-
Mie University Hospital
Tsu, 514 8507, Japan
-
Nagoya City University Hospital
Nagoya, 467 8602, Japan
-
Public Interest Incorporated Foundation Nipoon Life Saiseikai Nippon Life Hospital
Osaka, 550 0006, Japan
-
Teikyo University Hospital
Itabashi Ku, 173 8606, Japan
-
Tohoku University Hospital
Sendai, 980 8574, Japan
-
Tokyo Medical University Hospital
Shinjuku, 160 0023, Japan
Conditions
Explore the condition pages connected to this study.